| 000 | 01363 a2200385 4500 | ||
|---|---|---|---|
| 005 | 20250510214751.0 | ||
| 264 | 0 | _c19761020 | |
| 008 | 197610s 0 0 eng d | ||
| 022 | _a0004-4172 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aRouffy, J | |
| 245 | 0 | 0 |
_aAtilipidemic drugs. Part 5: Evaluation of the hypolipidemic effect of LF 178 in 191 patients affected by the atherogenic form of endogenous hyperlipoproteinemia (types IIa, IIb and IV). _h[electronic resource] |
| 260 |
_bArzneimittel-Forschung _c1976 |
||
| 300 |
_a901-6 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Comparative Study; Controlled Clinical Trial; Journal Article | ||
| 650 | 0 | 4 | _aClinical Trials as Topic |
| 650 | 0 | 4 |
_aClofibrate _xtherapeutic use |
| 650 | 0 | 4 | _aDrug Evaluation |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHypercholesterolemia _xdrug therapy |
| 650 | 0 | 4 |
_aHyperlipidemias _xdrug therapy |
| 650 | 0 | 4 |
_aHypolipidemic Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aLipoproteins, LDL _xblood |
| 650 | 0 | 4 |
_aLipoproteins, VLDL _xblood |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aPropionates _xtherapeutic use |
| 650 | 0 | 4 |
_aTriglycerides _xblood |
| 700 | 1 | _aDreux, C | |
| 700 | 1 | _aGoussault, Y | |
| 700 | 1 | _aDakkak, R | |
| 700 | 1 | _aRenson, F J | |
| 773 | 0 |
_tArzneimittel-Forschung _gvol. 26 _gno. 5 _gp. 901-6 |
|
| 999 |
_c180135 _d180135 |
||